Paper30582011
Establishment of X-linked Alport syndrome model mice with a Col4a5 R471X mutation.
Hashikami K and 5 others. Biochem Biophys Rep, 2019. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Establishment of X-linked Alport syndrome model mice with a Col4a5 R471X mutation. Papers, record 30582011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30582011
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10534397 | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | Genomics | 1999 | https://conductscience.org/library/papers/10534397 | PubMed |
| 2 | 10752524 | X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. | J Am Soc Nephrol | 2000 | https://conductscience.org/library/papers/10752524 | PubMed |
| 3 | 11839593 | Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome. | Am J Pathol | 2002 | https://conductscience.org/library/papers/11839593 | PubMed |
| 4 | 12105244 | Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling. | Nephrol Dial Transplant | 2002 | https://conductscience.org/library/papers/12105244 | PubMed |
| 5 | 12147777 | Animal models of Alport syndrome. | Nephrol Dial Transplant | 2002 | https://conductscience.org/library/papers/12147777 | PubMed |
| 6 | 12879362 | Genetic cause of X-linked Alport syndrome in a family of domestic dogs. | Mamm Genome | 2003 | https://conductscience.org/library/papers/12879362 | PubMed |
| 7 | 15086897 | Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene. | Kidney Int | 2004 | https://conductscience.org/library/papers/15086897 | PubMed |
| 8 | 15128880 | Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis. | Nephrol Dial Transplant | 2004 | https://conductscience.org/library/papers/15128880 | PubMed |
| 9 | 15153557 | Mouse model of X-linked Alport syndrome. | J Am Soc Nephrol | 2004 | https://conductscience.org/library/papers/15153557 | PubMed |
| 10 | 1689491 | Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/1689491 | PubMed |
| 11 | 17290292 | Choosing a mouse model to study the molecular pathobiology of Alport glomerulonephritis. | Kidney Int | 2007 | https://conductscience.org/library/papers/17290292 | PubMed |
| 12 | 20378821 | Genotype-phenotype correlation in X-linked Alport syndrome. | J Am Soc Nephrol | 2010 | https://conductscience.org/library/papers/20378821 | PubMed |
| 14 | 22461141 | Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative. | Pediatr Nephrol | 2013 | https://conductscience.org/library/papers/22461141 | PubMed |
| 15 | 2349482 | Identification of mutations in the COL4A5 collagen gene in Alport syndrome. | Science | 1990 | https://conductscience.org/library/papers/2349482 | PubMed |
| 16 | 23545779 | Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. | Cell Res | 2013 | https://conductscience.org/library/papers/23545779 | PubMed |
| 17 | 23643243 | One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. | Cell | 2013 | https://conductscience.org/library/papers/23643243 | PubMed |
| 18 | 26581810 | X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene. | Clin Exp Nephrol | 2016 | https://conductscience.org/library/papers/26581810 | PubMed |
| 19 | 27627812 | X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations. | PLoS One | 2016 | https://conductscience.org/library/papers/27627812 | PubMed |
| 20 | 29270492 | Natural History and Genotype-Phenotype Correlation in Female X-Linked Alport Syndrome. | Kidney Int Rep | 2017 | https://conductscience.org/library/papers/29270492 | PubMed |
| 21 | 4343992 | Alport's syndrome. Emphasizing electron microscopic studies of the glomerulus. | Am J Pathol | 1972 | https://conductscience.org/library/papers/4343992 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42303719 | Mouse model of X-linked Alport syndrome with K229X mutation in the COL4A5 gene. | Sci Rep | 2026 | https://conductscience.org/library/papers/42303719 | PubMed |
| 42074603 | A Novel Col4a5-G814fs Knock-In Mouse Model Reveals Phenotypic Heterogeneity Among Truncating COL4A5 Mutations in X-Linked Alport Syndrome. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42074603 | PubMed |
| 41290692 | Podocyte specific exon skipping after disease onset improves kidney pathology and function in a mouse model of Alport syndrome. | Sci Rep | 2025 | https://conductscience.org/library/papers/41290692 | PubMed |
| 40383823 | A novel mouse model for X-linked Alport syndrome induced by splicing mutation in the Col4a5 gene. | Sci Rep | 2025 | https://conductscience.org/library/papers/40383823 | PubMed |
| 37770589 | iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome. | Commun Biol | 2023 | https://conductscience.org/library/papers/37770589 | PubMed |
| 37122389 | Alport Syndrome: Clinical Spectrum and Therapeutic Advances. | Kidney Med | 2023 | https://conductscience.org/library/papers/37122389 | PubMed |
| 36968823 | A mouse model for X-linked Alport syndrome induced by Del-ATGG in the Col4a5 gene. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/36968823 | PubMed |
| 36699462 | Identification of COL4A4 variants in Chinese patients with familial hematuria. | Front Genet | 2022 | https://conductscience.org/library/papers/36699462 | PubMed |
| 36292778 | A Comparative Presentation of Mouse Models That Recapitulate Most Features of Alport Syndrome. | Genes (Basel) | 2022 | https://conductscience.org/library/papers/36292778 | PubMed |
| 35563876 | Genetic Kidney Diseases (GKDs) Modeling Using Genome Editing Technologies. | Cells | 2022 | https://conductscience.org/library/papers/35563876 | PubMed |
| 35243249 | NanoLuc reporters identify COL4A5 nonsense mutations susceptible to drug-induced stop codon readthrough. | iScience | 2022 | https://conductscience.org/library/papers/35243249 | PubMed |
| 34681722 | Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Alport Syndrome: A Primer for Clinicians. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34681722 | PubMed |
| 34675305 | Creation of X-linked Alport syndrome rat model with Col4a5 deficiency. | Sci Rep | 2021 | https://conductscience.org/library/papers/34675305 | PubMed |
| 34645753 | Slowly Progressive Male Alport Syndrome Evaluated by Serial Biopsy: Importance of Type IV Collagen Staining. | Intern Med | 2022 | https://conductscience.org/library/papers/34645753 | PubMed |
| 33718859 | A glycine substitution in the collagenous domain of Col4a3 in mice recapitulates late onset Alport syndrome. | Matrix Biol Plus | 2021 | https://conductscience.org/library/papers/33718859 | PubMed |
| 33214343 | Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome. | Kidney Res Clin Pract | 2020 | https://conductscience.org/library/papers/33214343 | PubMed |
| 33144651 | Bidirectional, non-necrotizing glomerular crescents are the critical pathology in X-linked Alport syndrome mouse model harboring nonsense mutation of human COL4A5. | Sci Rep | 2020 | https://conductscience.org/library/papers/33144651 | PubMed |
| 33086603 | Reactive Oxygen Species and Oxidative Stress in the Pathogenesis and Progression of Genetic Diseases of the Connective Tissue. | Antioxidants (Basel) | 2020 | https://conductscience.org/library/papers/33086603 | PubMed |
| 32488001 | Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5. | Nat Commun | 2020 | https://conductscience.org/library/papers/32488001 | PubMed |
| 31387942 | Basement membrane collagens and disease mechanisms. | Essays Biochem | 2019 | https://conductscience.org/library/papers/31387942 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| COL4A3 | 1285 | PubTator's text mining | https://conductscience.org/library/genes/1285 | NCBI Gene |
| COL4A4 | 1286 | PubTator's text mining | https://conductscience.org/library/genes/1286 | NCBI Gene |
| COL4A5 | 1287 | PubTator's text mining | https://conductscience.org/library/genes/1287 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30582011
GET https://conductscience.org/api/papers/v1/30582011/references?page=2